<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Subclinical hypothyroidism (HSC) is a relatively common thyroid dysfunction, characterized by the increase of the thyroid stimulating hormone (TSH) in the presence of normal free thyroxine values. Thyroid hormones are known for the cardiovascular effects, and the consequences of HSC on the cardiovascular system have become the focus of many studies lately. There are clear indications of the relationship between HSC and cardiovascular risk factors such as hypertension, dyslipidemia and atherosclerosis; also, HSC is associated with metabolic syndrome, BMI increase and cardiac insufficiency. Therefore, many clinical trials investigate the benefits and risks of HSC treatment with L-thyroxine.</p></abstract>

Subclinical hypothyroidism (HSC) is a relatively common thyroid dysfunction, characterized by the increase of the thyroid stimulating hormone (TSH) in the presence of normal free thyroxine values. Thyroid hormones are known for the cardiovascular effects, and the consequences of HSC on the cardiovascular system have become the focus of many studies lately. There are clear indications of the relationship between HSC and cardiovascular risk factors such as hypertension, dyslipidemia and atherosclerosis; also, HSC is associated with metabolic syndrome, BMI increase and cardiac insufficiency. Therefore, many clinical trials investigate the benefits and risks of HSC treatment with L-thyroxine.

Cardiovascular Risk in Subclinical Hypothyroidism

National Institute of Endocrinology „C.I. Parhon” Bucharest

Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Cardiovascular Risk in Subclinical Hypothyroidism"}

Subclinical hypothyroidism (HSC) is a relatively common thyroid dysfunction, characterized by the increase of the thyroid stimulating hormone (TSH) in the...

Cardiovascular Risk in Subclinical Hypothyroidism

Data publikacji: 20 lip 2018

Zakres stron: 51 - 60

DOI: https://doi.org/10.2478/inmed-2018-0022

Słowa kluczowe
subclinical hypothyroidism, cardiovascular risk factors, L-thyroxine substitution therapy

© 2018 Mariana Dobrescu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Cardiovascular Risk in Subclinical Hypothyroidism

Data publikacji: 20 lip 2018

Zakres stron: 51 - 60

DOI: https://doi.org/10.2478/inmed-2018-0022

Słowa kluczowesubclinical hypothyroidism, cardiovascular risk factors, L-thyroxine substitution therapy

© 2018 Mariana Dobrescu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Słowa kluczowe
subclinical hypothyroidism, cardiovascular risk factors, L-thyroxine substitution therapy